DEFINING RISK DEGREE OF OVARIAN CANCER RECURRENCESUSING MORPHOMETRICAL AND IMMUNOHISTOCHEMICAL RESEARCOF A PRIMARY TUMOR
- 作者: Novichkov Y.V1
-
隶属关系:
- 期: 卷 6, 编号 3 (2009)
- 页面: 70-73
- 栏目: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/140275
- ID: 140275
如何引用文章
全文:
详细
Quantimetrical and immunohistichemical characteristics of ovarian cancer with high risk of relapse compared with
ovarian carcinoma without recurrences were studied on operative and biopsy material from 120 patients. It was established
that serous ovarian carcinoma with high risk of tumor relapse had a lesser cellular size, but a higher nuclear-cellular ratio.
Morphometrical criteria of early cancer relapse (up to 6 months) and late recurrences of tumor growth were detected.
Immunohistochemical parameters (mt p53, PCNA) allow a reliable prediction of relapse of serous ovarian cancer.
ovarian carcinoma without recurrences were studied on operative and biopsy material from 120 patients. It was established
that serous ovarian carcinoma with high risk of tumor relapse had a lesser cellular size, but a higher nuclear-cellular ratio.
Morphometrical criteria of early cancer relapse (up to 6 months) and late recurrences of tumor growth were detected.
Immunohistochemical parameters (mt p53, PCNA) allow a reliable prediction of relapse of serous ovarian cancer.
参考
- Аксель Е. М., Давыдов М. И. // Злокачественные новообразования в России и странах СНГ в 2000 г. - М., 2002. - С. 85-106.
- Бохман Я. В. Руководство по онкогинекологии. - Л.: «Гиппократ», 1989. - С. 384-419.
- Винокуров В. Л. Рак яичников: закономерности метастазирования и выбор адекватного лечения больных. - СПб: ООО «Издательство ФОЛИАНТ», 2004. - 336 с.
- Орлова Р. В. // Практическая онкология. - 2000. - № 4. - С. 42-44.
- Пожарисский К. М., Леенман Е. Е. // Архив патологии. - 2000. - Т. 62, № 5. - С. 3-11.
- Урманчеева А. Ф. // Практическая онкология - 2002. - Т. 3, № 4. - С. 295-304.
- Berek J. S., Bertelsen K., du Bois A., et al. // Ann. Oncol. - 1999. - № 10 (suppl. 1). - P. 87-92.
- Ozols R. F. // 10th International Congress on AntiCancer Treatment. - Paris, 2000. - P. 34-35.
补充文件
